Buy Merus Stock | MRUS Stock Price & Latest News | Public.com

Merus

$0.00 (0.00%)Today

    About MRUS

    Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Rating

    What Wall St. analysts suggest for this stock

    1.5

    Price Targets

    What analysts think this stock will be worth

    $13.68
    current
    $20.55
    average

    Events

    List of events that could affect this stock.

    11May

    Earnings data Q1 2020

    03Aug

    Earnings data Q2 2020

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.24
    -0.47
    -0.71
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.59

    Actual EPS
    Q3 2020

    Stats

    Market Cap$417,61M
    Volume5,38k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$20.95
    1 Year Low$10.19
    Open$14.50
    High$14.66
    Low$13.55

    Buy any stock with any amount of money.

    Download the App
    Download the app